Skip to main navigation Skip to search Skip to main content

Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial

  • SELECT Trial Investigators

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)773-786
Number of pages14
JournalThe Lancet
Volume404
Issue number10454
DOIs
StatePublished - Aug 24 2024

ASJC Scopus Subject Areas

  • General Medicine

Cite this